Dolutegravir Sodium: Potent Antiviral Raw Material for HIV Treatment and Prevention

A key component in modern HIV management, offering high efficacy and a favorable safety profile.

Get a Quote & Sample

Key Advantages

High Efficacy & Low Resistance

Dolutegravir Sodium offers exceptional efficacy in combating HIV, coupled with a low risk of developing drug resistance, making it a preferred choice in antiviral therapy.

Rapid Absorption & Bioavailability

The stable chemical structure ensures rapid absorption after oral administration, allowing the drug to reach effective therapeutic concentrations quickly, aiding patients in managing their condition.

Broad Application in HIV Management

From first-line treatment for adults and children to salvage therapy for drug-resistant strains and crucial roles in Dolutegravir Sodium PrEP and Dolutegravir Sodium PEP, its versatility is a major advantage.

Key Applications

HIV Treatment

As a core drug in first-line antiviral treatment for adults and children, and in salvage therapy for drug-resistant patients, Dolutegravir Sodium is fundamental to current HIV treatment protocols.

HIV Prevention (PrEP/PEP)

The efficacy and safety profile of Dolutegravir Sodium make it an important option for pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) to reduce HIV infection risk.

Pharmaceutical Intermediate

This raw material is a critical intermediate in the synthesis of various antiretroviral drugs, contributing to ongoing pharmaceutical intermediate for antiretrovirals research.

Research & Development

Used in research settings to explore new antiviral therapies and understand the complex mechanisms of HIV replication, supporting advanced HIV therapeutics development.